Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, Hwallip | - |
dc.contributor.author | Kim, Daeho | - |
dc.contributor.author | Cho, Yubin | - |
dc.contributor.author | Kim, Dongjoo | - |
dc.contributor.author | Kim, Seok Hyeon | - |
dc.date.accessioned | 2022-07-11T05:14:43Z | - |
dc.date.available | 2022-07-11T05:14:43Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2018-11 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/149110 | - |
dc.description.abstract | This study examined the add-on efficacy of eye movement desensitization and reprocessing (EMDR) therapy among adult civilians with post-traumatic stress disorder (PTSD) who continued to be symptomatic after more than 12 weeks of initial antidepressant treatment. Scores for the Clinician Administered PTSD Scale (CAPS) were rated pre- and post-EMDR and at a 6-month follow-up. After an average of six sessions of EMDR treatment, seven of 14 patients (50%) showed more than a 30% decrease in CAPS score and eight (57%) no longer met the criteria for PTSD. Our results indicate that EMDR could be successfully added after failure of initial pharmacotherapy for PTSD. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Academy of Medical Science | - |
dc.title | Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Daeho | - |
dc.contributor.affiliatedAuthor | Kim, Seok Hyeon | - |
dc.identifier.doi | 10.3346/jkms.2018.33.e306 | - |
dc.identifier.scopusid | 2-s2.0-85057085691 | - |
dc.identifier.wosid | 000451214000004 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.33, no.48, pp.1 - 6 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 33 | - |
dc.citation.number | 48 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 6 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002404826 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | COGNITIVE-BEHAVIOR THERAPY | - |
dc.subject.keywordPlus | TREATMENT-RESISTANT PTSD | - |
dc.subject.keywordPlus | SERTRALINE TREATMENT | - |
dc.subject.keywordPlus | CAMBODIAN REFUGEES | - |
dc.subject.keywordPlus | PANIC-ATTACKS | - |
dc.subject.keywordPlus | PSYCHOTHERAPY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | PLACEBO | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | CBT | - |
dc.subject.keywordAuthor | PTSD | - |
dc.subject.keywordAuthor | Drug Therapy | - |
dc.subject.keywordAuthor | Antidepressants | - |
dc.subject.keywordAuthor | EMDR | - |
dc.identifier.url | https://jkms.org/DOIx.php?id=10.3346/jkms.2018.33.e306 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.